Cadila Pharma Fund Rs 200 Cr in new API Manufacturing Plant at Dahej

Cadila Pharmaceuticals, located in Ahmedabad, has opened its state-of-the-art Active Pharmaceutical Ingredients (API) Plant in Dahej, Bharuch district. The Rs 200 crore facility is outfitted with the latest Distributed Control System (DCS) automation technology, representing a key milestone in Cadila Pharmaceuticals' commitment to innovation and quality in medicine manufacture.

Dr H. G. Koshia, Food Drug Commissioner for Gujarat, and Dr M. P. Nakarani, Assistant Commissioner of FDCA, Baruch Circle, graced the event with their presence, as per biospectrumindia.

Speaking on the occasion, Biswajit Mitra, Chief Mentoring Officer at Cadila Pharmaceuticals and Convener Pharma Panel, CII Gujarat State, said, “The DCS technology used in this facility will allow us to produce APIs with a high level of purity and consistency, while also reducing the environmental impact. The implementation of the plant project will further extend our impact by generating employment opportunities for both permanent and contractual positions, thereby continuing our dedication to creating positive social change. ” 

Cadila Pharmaceuticals had previously inked an MoU with the Gujarat government to invest Rs 1,000 crore in Gujarat. One of the projects for which the MoU was signed is the Dahej API plant.

Cadila Pharmaceuticals' new API production facility will allow the firm to continue to supply high-quality products to clients while also expanding its reach into new markets.